Preparation of biodegradable nanoparticles of tri-block PLA–PEG–PLA copolymer and determination of factors controlling the particle size using artificial neural network

The purpose of this study was to prepare nanoparticles made of tri-block poly(lactide)–poly(ethylene glycol)–poly (lactide) (PLA–PEG–PLA) with controlled size as drug carrier. Artificial neural networks (ANNs) were used to identify factors which influence particle size. In this way, PLA–PEG–PLA was synthesized and was made into nanoparticles by nanoprecipitation under different conditions. The copolymer and the resulting nanoparticles were characterized by various techniques such as proton nuclear magnetic resonance spectroscopy, Fourier transform infrared spectroscopy, gel permeation chromatography, photon correlation spectroscopy and scanning electron microscopy. The developed model was assessed and found to be of high quality. The model was then used to survey the effects of processing factors including polymer concentration, amount of drug, solvent ratio and mixing rate on particle size of polymeric nanoparticles. It was observed that polymer concentration is the most affecting parameter on nanoparticle size distribution. The results demonstrate the potential of ANNs in modelling and identification of critical parameters effective on final particle size.

[1]  M. L. Ferreira,et al.  PLA nano- and microparticles for drug delivery: an overview of the methods of preparation. , 2007, Macromolecular bioscience.

[2]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[3]  Tadashi Hattori,et al.  Analysis of factors controlling catalytic activity by neural network , 2006 .

[4]  K. Sakurai,et al.  Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro. , 1999, International journal of pharmaceutics.

[5]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development: Computer Aided Formulation Design , 1994 .

[6]  Jie Ren,et al.  Particle size and distribution of biodegradable poly‐D,L‐lactide‐co‐poly(ethylene glycol) block polymer nanoparticles prepared by nanoprecipitation , 2005 .

[7]  Chee Peng Lim,et al.  Use of Artificial Neural Networks to Predict Drug Dissolution Profiles and Evaluation of Network Performance Using Similarity Factor , 2000, Pharmaceutical Research.

[8]  Névine Rizkalla,et al.  Artificial Neural Networks: Comparison of Two Programs for Modeling a Process of Nanoparticle Preparation , 2005, Drug development and industrial pharmacy.

[9]  Ilia Fishbein,et al.  Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[11]  M. Turkoğlu,et al.  Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks. , 2000, Journal of microencapsulation.

[12]  S. Venkatraman,et al.  ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics. , 2007, International journal of pharmaceutics.

[13]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[14]  C. van Nostrum,et al.  Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. , 2007, Biomaterials.

[15]  S. Agatonovic-Kustrin,et al.  Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.

[16]  H. Chrystyn,et al.  Determination of factors controlling the particle size in nanoemulsions using Artificial Neural Networks. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  Eugeniusz Molga,et al.  Neural network approach to support modelling of chemical reactors: problems, resolutions, criteria of application , 2003 .

[18]  Hong-Zhuan Chen,et al.  In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[20]  Christine Vauthier,et al.  Methods for the Preparation and Manufacture of Polymeric Nanoparticles , 2009, Pharmaceutical Research.

[21]  Kozo Takayama,et al.  Formulation Optimization of Paclitaxel Carried by PEGylated Emulsions Based on Artificial Neural Network , 2004, Pharmaceutical Research.

[22]  Feng Min,et al.  Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier. , 2005, International journal of pharmaceutics.

[23]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[24]  T. Hattori,et al.  Partial differentiation of neural network for the analysis of factors controlling catalytic activity , 2007 .

[25]  J. Venitz,et al.  Comparison of Neural Network and Multiple Linear Regression as Dissolution Predictors# , 2003, Drug development and industrial pharmacy.

[26]  S. Feng,et al.  Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. , 2004, Biomaterials.

[27]  S. Davis,et al.  An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. , 1993, Biochimica et biophysica acta.

[28]  Hatem Fessi,et al.  Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Cees W. M. Bastiaansen,et al.  ABA Type Copolymers of Lactide with Poly(ethylene glycol). Kinetic, Mechanistic, and Model Studies , 1995 .

[30]  Yixin Chen,et al.  Application of artificial neural networks in the design of controlled release drug delivery systems. , 2003, Advanced drug delivery reviews.

[31]  Hideyoshi Harashima,et al.  Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes , 1994, Pharmaceutical Research.

[32]  Svetlana Ibrić,et al.  The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[33]  P. Legrand,et al.  Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. , 2000, Journal of pharmaceutical sciences.

[34]  Xuesi Chen,et al.  Triblock poly(lactic acid)‐b‐poly(ethylene glycol)‐b‐poly(lactic acid)/paclitaxel conjugates: Synthesis, micellization, and cytotoxicity , 2007 .

[35]  S. Lesieur,et al.  Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. , 2007, International journal of pharmaceutics.

[36]  Raymond C. Rowe,et al.  Intelligent Software for Product Formulation , 1998 .

[37]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[38]  J. Nah,et al.  Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. , 2000, International journal of pharmaceutics.